Selected research
Industry Research
Single-Cell Multi-Omics Analysis Platform Industry Research Report 2026
Market perspective
The global Single-Cell Multi-Omics Analysis Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Single-Cell Multi-Omics Analysis Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Single-Cell Multi-Omics Analysis Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Single-Cell Multi-Omics Analysis Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Single-Cell Multi-Omics Analysis Platform include Parse Biosciences, Mission Bio, BioLegend, Singleron Biotechnologies, MGI Tech, BioSkryb Genomics, Scale Biosciences, Takara Bio and Cellenion, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Single-Cell Multi-Omics Analysis Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Single-Cell Multi-Omics Analysis Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Single-Cell Multi-Omics Analysis Platform Market by Company
Parse Biosciences
Mission Bio
BioLegend
Singleron Biotechnologies
MGI Tech
BioSkryb Genomics
Scale Biosciences
Takara Bio
Cellenion
Dolomite Bio
Partek
BioTuring
QIAGEN
ROSALIND
CS Genetics
10x Genomics
BD
Illumina
Single-Cell Multi-Omics Analysis Platform Segment by Type
Transcriptome and Epigenome Platforms
Transcriptome and Proteome Platforms
Genome and Transcriptome Platforms
Genome and Proteome Platforms
Three-or-More-Omics Platforms
Other Multi-Omics Platforms
Single-Cell Multi-Omics Analysis Platform Segment by Application
Disease Mechanism Research
Drug Target and Biomarker Discovery
Cell and Gene Therapy Characterization
Clinical and Translational Research
Cell Atlas and Developmental Biology
Other Life Science Research
Single-Cell Multi-Omics Analysis Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single-Cell Multi-Omics Analysis Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Single-Cell Multi-Omics Analysis Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single-Cell Multi-Omics Analysis Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Single-Cell Multi-Omics Analysis Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transcriptome and Epigenome Platforms
- Transcriptome and Proteome Platforms
- Genome and Transcriptome Platforms
- Genome and Proteome Platforms
- Three-or-More-Omics Platforms
- Other Multi-Omics Platforms
Applications
- Disease Mechanism Research
- Drug Target and Biomarker Discovery
- Cell and Gene Therapy Characterization
- Clinical and Translational Research
- Cell Atlas and Developmental Biology
- Other Life Science Research
Companies covered
- Parse Biosciences
- Mission Bio
- BioLegend
- Singleron Biotechnologies
- MGI Tech
- BioSkryb Genomics
- Scale Biosciences
- Takara Bio
- Cellenion
- Dolomite Bio
- Partek
- BioTuring
- QIAGEN
- ROSALIND
- CS Genetics
- 10x Genomics
- BD
- Illumina
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Single-Cell Multi-Omics Analysis Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Transcriptome and Epigenome Platforms
- 2.2.3 Transcriptome and Proteome Platforms
- 2.2.4 Genome and Transcriptome Platforms
- 2.2.5 Genome and Proteome Platforms
- 2.2.6 Three-or-More-Omics Platforms
- 2.2.7 Other Multi-Omics Platforms
- 2.3 Single-Cell Multi-Omics Analysis Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Disease Mechanism Research
- 2.3.3 Drug Target and Biomarker Discovery
- 2.3.4 Cell and Gene Therapy Characterization
- 2.3.5 Clinical and Translational Research
- 2.3.6 Cell Atlas and Developmental Biology
- 2.3.7 Other Life Science Research
- 2.4 Assumptions and Limitations
3 Single-Cell Multi-Omics Analysis Platform Breakdown Data by Type
- 3.1 Global Single-Cell Multi-Omics Analysis Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Single-Cell Multi-Omics Analysis Platform Forecasted Market Size by Type (2027-2032)
4 Single-Cell Multi-Omics Analysis Platform Breakdown Data by Application
- 4.1 Global Single-Cell Multi-Omics Analysis Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Single-Cell Multi-Omics Analysis Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Single-Cell Multi-Omics Analysis Platform Market Perspective (2021-2032)
- 5.2 Global Single-Cell Multi-Omics Analysis Platform Growth Trends by Region
- 5.2.1 Global Single-Cell Multi-Omics Analysis Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Single-Cell Multi-Omics Analysis Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Single-Cell Multi-Omics Analysis Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Single-Cell Multi-Omics Analysis Platform Market Dynamics
- 5.3.1 Single-Cell Multi-Omics Analysis Platform Industry Trends
- 5.3.2 Single-Cell Multi-Omics Analysis Platform Market Drivers
- 5.3.3 Single-Cell Multi-Omics Analysis Platform Market Challenges
- 5.3.4 Single-Cell Multi-Omics Analysis Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Single-Cell Multi-Omics Analysis Platform Players by Revenue
- 6.1.1 Global Top Single-Cell Multi-Omics Analysis Platform Players by Revenue (2021-2026)
- 6.1.2 Global Single-Cell Multi-Omics Analysis Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Single-Cell Multi-Omics Analysis Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Single-Cell Multi-Omics Analysis Platform Head Office and Area Served
- 6.4 Global Single-Cell Multi-Omics Analysis Platform Players, Product Type & Application
- 6.5 Global Single-Cell Multi-Omics Analysis Platform Manufacturers Established Date
- 6.6 Global Single-Cell Multi-Omics Analysis Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Single-Cell Multi-Omics Analysis Platform Market Size (2021-2032)
- 7.2 North America Single-Cell Multi-Omics Analysis Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Single-Cell Multi-Omics Analysis Platform Market Size by Country (2021-2026)
- 7.4 North America Single-Cell Multi-Omics Analysis Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Single-Cell Multi-Omics Analysis Platform Market Size (2021-2032)
- 8.2 Europe Single-Cell Multi-Omics Analysis Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Single-Cell Multi-Omics Analysis Platform Market Size by Country (2021-2026)
- 8.4 Europe Single-Cell Multi-Omics Analysis Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Single-Cell Multi-Omics Analysis Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Single-Cell Multi-Omics Analysis Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Single-Cell Multi-Omics Analysis Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Single-Cell Multi-Omics Analysis Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Single-Cell Multi-Omics Analysis Platform Market Size (2021-2032)
- 10.2 South America Single-Cell Multi-Omics Analysis Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Single-Cell Multi-Omics Analysis Platform Market Size by Country (2021-2026)
- 10.4 South America Single-Cell Multi-Omics Analysis Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Parse Biosciences
- 12.1.1 Parse Biosciences Company Information
- 12.1.2 Parse Biosciences Business Overview
- 12.1.3 Parse Biosciences Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.1.4 Parse Biosciences Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.1.5 Parse Biosciences Recent Developments
- 12.2 Mission Bio
- 12.2.1 Mission Bio Company Information
- 12.2.2 Mission Bio Business Overview
- 12.2.3 Mission Bio Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.2.4 Mission Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.2.5 Mission Bio Recent Developments
- 12.3 BioLegend
- 12.3.1 BioLegend Company Information
- 12.3.2 BioLegend Business Overview
- 12.3.3 BioLegend Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.3.4 BioLegend Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.3.5 BioLegend Recent Developments
- 12.4 Singleron Biotechnologies
- 12.4.1 Singleron Biotechnologies Company Information
- 12.4.2 Singleron Biotechnologies Business Overview
- 12.4.3 Singleron Biotechnologies Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.4.4 Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.4.5 Singleron Biotechnologies Recent Developments
- 12.5 MGI Tech
- 12.5.1 MGI Tech Company Information
- 12.5.2 MGI Tech Business Overview
- 12.5.3 MGI Tech Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.5.4 MGI Tech Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.5.5 MGI Tech Recent Developments
- 12.6 BioSkryb Genomics
- 12.6.1 BioSkryb Genomics Company Information
- 12.6.2 BioSkryb Genomics Business Overview
- 12.6.3 BioSkryb Genomics Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.6.4 BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.6.5 BioSkryb Genomics Recent Developments
- 12.7 Scale Biosciences
- 12.7.1 Scale Biosciences Company Information
- 12.7.2 Scale Biosciences Business Overview
- 12.7.3 Scale Biosciences Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.7.4 Scale Biosciences Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.7.5 Scale Biosciences Recent Developments
- 12.8 Takara Bio
- 12.8.1 Takara Bio Company Information
- 12.8.2 Takara Bio Business Overview
- 12.8.3 Takara Bio Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.8.4 Takara Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.8.5 Takara Bio Recent Developments
- 12.9 Cellenion
- 12.9.1 Cellenion Company Information
- 12.9.2 Cellenion Business Overview
- 12.9.3 Cellenion Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.9.4 Cellenion Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.9.5 Cellenion Recent Developments
- 12.10 Dolomite Bio
- 12.10.1 Dolomite Bio Company Information
- 12.10.2 Dolomite Bio Business Overview
- 12.10.3 Dolomite Bio Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.10.4 Dolomite Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.10.5 Dolomite Bio Recent Developments
- 12.11 Partek
- 12.11.1 Partek Company Information
- 12.11.2 Partek Business Overview
- 12.11.3 Partek Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.11.4 Partek Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.11.5 Partek Recent Developments
- 12.12 BioTuring
- 12.12.1 BioTuring Company Information
- 12.12.2 BioTuring Business Overview
- 12.12.3 BioTuring Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.12.4 BioTuring Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.12.5 BioTuring Recent Developments
- 12.13 QIAGEN
- 12.13.1 QIAGEN Company Information
- 12.13.2 QIAGEN Business Overview
- 12.13.3 QIAGEN Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.13.4 QIAGEN Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.13.5 QIAGEN Recent Developments
- 12.14 ROSALIND
- 12.14.1 ROSALIND Company Information
- 12.14.2 ROSALIND Business Overview
- 12.14.3 ROSALIND Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.14.4 ROSALIND Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.14.5 ROSALIND Recent Developments
- 12.15 CS Genetics
- 12.15.1 CS Genetics Company Information
- 12.15.2 CS Genetics Business Overview
- 12.15.3 CS Genetics Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.15.4 CS Genetics Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.15.5 CS Genetics Recent Developments
- 12.16 10x Genomics
- 12.16.1 10x Genomics Company Information
- 12.16.2 10x Genomics Business Overview
- 12.16.3 10x Genomics Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.16.4 10x Genomics Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.16.5 10x Genomics Recent Developments
- 12.17 BD
- 12.17.1 BD Company Information
- 12.17.2 BD Business Overview
- 12.17.3 BD Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.17.4 BD Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.17.5 BD Recent Developments
- 12.18 Illumina
- 12.18.1 Illumina Company Information
- 12.18.2 Illumina Business Overview
- 12.18.3 Illumina Revenue in Single-Cell Multi-Omics Analysis Platform Business (2021-2026)
- 12.18.4 Illumina Single-Cell Multi-Omics Analysis Platform Product Portfolio
- 12.18.5 Illumina Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst